KRON
Price
$1.10
Change
+$0.05 (+4.76%)
Updated
Feb 22, 6:59 PM EST
26 days until earnings call
MDGL
Price
$248.53
Change
+$20.29 (+8.89%)
Updated
Feb 22, 6:59 PM EST
Earnings call today
Ad is loading...

KRON vs MDGL ᐉ Comparison: Which is Better to Invest?

Header iconKRON vs MDGL Comparison
Open Charts KRON vs MDGLBanner chart's image
Kronos Bio
Price$1.10
Change+$0.05 (+4.76%)
Volume$116.07K
CapitalizationN/A
Madrigal Pharmaceuticals
Price$248.53
Change+$20.29 (+8.89%)
Volume$199.66K
CapitalizationN/A
View a ticker or compare two or three
KRON vs MDGL Comparison Chart

Loading...

KRONDaily Signal changed days agoGain/Loss if shorted
 
Show more...
MDGLDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
KRON vs. MDGL commentary
Feb 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KRON is a Hold and MDGL is a Buy.

COMPARISON
Comparison
Feb 23, 2024
Stock price -- (KRON: $1.10 vs. MDGL: $248.53)
Brand notoriety: KRON and MDGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KRON: 85% vs. MDGL: 45%
Market capitalization -- KRON: $64.15M vs. MDGL: $4.91B
KRON [@Biotechnology] is valued at $64.15M. MDGL’s [@Biotechnology] market capitalization is $4.91B. The market cap for tickers in the [@Biotechnology] industry ranges from $538.15B to $0. The average market capitalization across the [@Biotechnology] industry is $2.55B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KRON’s FA Score shows that 1 FA rating(s) are green whileMDGL’s FA Score has 0 green FA rating(s).

  • KRON’s FA Score: 1 green, 4 red.
  • MDGL’s FA Score: 0 green, 5 red.
According to our system of comparison, both KRON and MDGL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KRON’s TA Score shows that 5 TA indicator(s) are bullish while MDGL’s TA Score has 7 bullish TA indicator(s).

  • KRON’s TA Score: 5 bullish, 4 bearish.
  • MDGL’s TA Score: 7 bullish, 4 bearish.
According to our system of comparison, MDGL is a better buy in the short-term than KRON.

Price Growth

KRON (@Biotechnology) experienced а +1.85% price change this week, while MDGL (@Biotechnology) price change was +11.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +16.06%, and the average quarterly price growth was +36.45%.

Reported Earning Dates

KRON is expected to report earnings on May 08, 2024.

MDGL is expected to report earnings on May 07, 2024.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for KRON with price predictions.
OPEN
A.I.dvisor published
a Summary for MDGL with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
MDGL($4.91B) has a higher market cap than KRON($64.1M). MDGL YTD gains are higher at: 7.412 vs. KRON (-12.000). KRON has higher annual earnings (EBITDA): -125.94M vs. MDGL (-336.4M). MDGL has more cash in the bank: 232M vs. KRON (187M). KRON has less debt than MDGL: KRON (29.5M) vs MDGL (117M). KRON has higher revenues than MDGL: KRON (4M) vs MDGL (0).
KRONMDGLKRON / MDGL
Capitalization64.1M4.91B1%
EBITDA-125.94M-336.4M37%
Gain YTD-12.0007.412-162%
P/E RatioN/AN/A-
Revenue4M0-
Total Cash187M232M81%
Total Debt29.5M117M25%
FUNDAMENTALS RATINGS
MDGL: Fundamental Ratings
MDGL
OUTLOOK RATING
1..100
59
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
PROFIT vs RISK RATING
1..100
40
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
50
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KRONMDGL
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
78%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
81%
Momentum
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
76%
MACD
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
76%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
75%
Advances
ODDS (%)
Bullish Trend 8 days ago
80%
Bullish Trend 7 days ago
78%
Declines
ODDS (%)
Bearish Trend 21 days ago
90%
Bearish Trend 2 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
77%
Bullish Trend 1 day ago
77%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
74%
View a ticker or compare two or three
Ad is loading...
KRONDaily Signal changed days agoGain/Loss if shorted
 
Show more...
MDGLDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CRUZ21.910.40
+1.85%
Defiance Hotel, Airline, and Cruise ETF
JANW31.030.22
+0.71%
AllianzIM US Large Cap Buffer20 Jan ETF
BNO29.980.14
+0.47%
United States Brent Oil
ICF56.790.08
+0.14%
iShares Cohen & Steers REIT ETF
AMZD15.11-0.54
-3.45%
Direxion Daily AMZN Bear 1X ETF

KRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, KRON has been loosely correlated with MDGL. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if KRON jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KRON
1D Price
Change %
KRON100%
+4.27%
MDGL - KRON
44%
Loosely correlated
+8.89%
CYTK - KRON
42%
Loosely correlated
-1.19%
EDIT - KRON
39%
Loosely correlated
-0.88%
VERA - KRON
38%
Loosely correlated
+9.91%
AXON - KRON
38%
Loosely correlated
+2.96%
More